Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed. The page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding/operating status notice from the page. No other content changes are evident.SummaryDifference0.4%

- Check36 days agoChange DetectedDate-related metadata in the Study Record Dates was updated with new entries (2025-11-03 and 2025-10-31) and an 'Last Update Posted (Estimated)' label; older entries such as 'Last Update Posted' and dates from 2025-04/2025-05 were removed.SummaryDifference0.3%

- Check43 days agoChange DetectedNo significant changes to core study details were detected; changes appear cosmetic or administrative, not affecting the study's purpose or patient eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check79 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.